Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reply on that "other" hub

No, confidentiality on the one hand does not affect materiality requirements on the other hand.

Thus, if they released the K 'early', prior to finalization of the settlement, then that is a timing issue and does not preclude them from an announcement later if, in fact, the numbers are large enough with respect to materiality to warrant a filing. I don't know if their 'early' filing was on purpose to sidestep (at least temporarily) the public airing of this event, i.e. in the K, or whether this settlement rises to the level of materiality and must be reported upon for accounting purposes at all (regardless of whether terms were redacted in legal filings).

Share
New Message
Please login to post a reply